William Maughan
Stock Analyst at Clear Street
(4.61)
# 889
Out of 4,486 analysts
140
Total ratings
52.6%
Success rate
21.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by William Maughan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRYS Krystal Biotech | Maintained: Buy | $338 → $311 | $374.68 | -17.00% | 5 | May 4, 2026 | |
| SMMT Summit Therapeutics | Maintained: Buy | $32 → $31 | $15.93 | +94.60% | 6 | May 1, 2026 | |
| WVE Wave Life Sciences | Maintained: Buy | $39 → $36 | $6.32 | +469.62% | 7 | Apr 28, 2026 | |
| ANNX Annexon | Maintained: Buy | $17 | $5.96 | +185.23% | 2 | Mar 30, 2026 | |
| BEAM Beam Therapeutics | Maintained: Buy | $37 | $35.32 | +4.76% | 5 | Mar 25, 2026 | |
| CLLS Cellectis | Maintained: Buy | $9 | $3.29 | +173.56% | 2 | Mar 20, 2026 | |
| KRRO Korro Bio | Maintained: Buy | $18 | $14.06 | +28.02% | 5 | Mar 13, 2026 | |
| IPSC Century Therapeutics | Maintained: Buy | $6.6 | $2.40 | +175.00% | 10 | Mar 13, 2026 | |
| MOLN Molecular Partners AG | Maintained: Buy | $8 | $4.00 | +100.00% | 4 | Mar 13, 2026 | |
| BNTX BioNTech SE | Reiterated: Buy | $181 → $167 | $93.93 | +77.79% | 21 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4.6 | $3.65 | +26.03% | 3 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $130 | $93.34 | +39.28% | 2 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $14.83 | +203.44% | 4 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $1.83 | +610.38% | 2 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 → $28 | $9.66 | +189.86% | 6 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 → $27 | $13.48 | +100.30% | 11 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $45 → $50 | $61.89 | -19.21% | 4 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $67 | $31.94 | n/a | 4 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 | $12.77 | n/a | 6 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $9 | $2.99 | n/a | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 | $14.90 | n/a | 5 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $15 | $3.30 | n/a | 5 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $91 → $106 | $81.80 | n/a | 7 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 | $4.35 | n/a | 7 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $10 → $5 | $32.56 | n/a | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $208.46 | n/a | 1 | Sep 5, 2022 |
Krystal Biotech
May 4, 2026
Maintained: Buy
Price Target: $338 → $311
Current: $374.68
Upside: -17.00%
Summit Therapeutics
May 1, 2026
Maintained: Buy
Price Target: $32 → $31
Current: $15.93
Upside: +94.60%
Wave Life Sciences
Apr 28, 2026
Maintained: Buy
Price Target: $39 → $36
Current: $6.32
Upside: +469.62%
Annexon
Mar 30, 2026
Maintained: Buy
Price Target: $17
Current: $5.96
Upside: +185.23%
Beam Therapeutics
Mar 25, 2026
Maintained: Buy
Price Target: $37
Current: $35.32
Upside: +4.76%
Cellectis
Mar 20, 2026
Maintained: Buy
Price Target: $9
Current: $3.29
Upside: +173.56%
Korro Bio
Mar 13, 2026
Maintained: Buy
Price Target: $18
Current: $14.06
Upside: +28.02%
Century Therapeutics
Mar 13, 2026
Maintained: Buy
Price Target: $6.6
Current: $2.40
Upside: +175.00%
Molecular Partners AG
Mar 13, 2026
Maintained: Buy
Price Target: $8
Current: $4.00
Upside: +100.00%
BioNTech SE
Mar 11, 2026
Reiterated: Buy
Price Target: $181 → $167
Current: $93.93
Upside: +77.79%
Mar 10, 2026
Maintained: Buy
Price Target: $4.6
Current: $3.65
Upside: +26.03%
Mar 10, 2026
Reiterated: Buy
Price Target: $100 → $130
Current: $93.34
Upside: +39.28%
Mar 6, 2026
Reiterated: Buy
Price Target: $45
Current: $14.83
Upside: +203.44%
Mar 6, 2026
Maintained: Buy
Price Target: $13
Current: $1.83
Upside: +610.38%
Mar 2, 2026
Maintained: Buy
Price Target: $21 → $28
Current: $9.66
Upside: +189.86%
Feb 26, 2026
Maintained: Buy
Price Target: $29 → $27
Current: $13.48
Upside: +100.30%
Nov 11, 2025
Maintained: Hold
Price Target: $45 → $50
Current: $61.89
Upside: -19.21%
May 23, 2024
Maintained: Hold
Price Target: $67
Current: $31.94
Upside: n/a
May 15, 2024
Maintained: Buy
Price Target: $24
Current: $12.77
Upside: n/a
May 9, 2024
Maintained: Buy
Price Target: $11 → $9
Current: $2.99
Upside: n/a
May 9, 2024
Maintained: Buy
Price Target: $38
Current: $14.90
Upside: n/a
May 9, 2024
Maintained: Buy
Price Target: $16 → $15
Current: $3.30
Upside: n/a
May 3, 2024
Maintained: Hold
Price Target: $91 → $106
Current: $81.80
Upside: n/a
Feb 20, 2024
Maintained: Buy
Price Target: $60
Current: $4.35
Upside: n/a
Nov 15, 2022
Downgraded: Hold
Price Target: $10 → $5
Current: $32.56
Upside: n/a
Sep 5, 2022
Reiterated: Buy
Price Target: n/a
Current: $208.46
Upside: n/a